Open AccessTofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis
Author(s) -
Hablot Julie,
Ferhat Maroua,
Lavelle Aonghus,
Salem Fatouma,
Taieb Mahdia,
Medvedovic Jasna,
Kindt Nadège,
Reboul Pascal,
Cailotto Frédéric,
Jouzeau JeanYves,
Eberl Gérard,
Sokol Harry,
Moulin David
Publication year - 2020
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.163
Subject(s) - tofacitinib , dysbiosis , immunology , rheumatoid arthritis , medicine , pathogenesis , gut flora , immune system , arthritis , mucosal immunology , immunity , autoimmunity , abatacept , antibody , rituximab